A Promising Way To Treat Specific Lymphoma

A Promising Way To Treat Specific Lymphoma.
Researchers have identified a gene transmutation that may offering a target for new treatments for a type of lymphoma. The set found that a mutation of the MYD88 gene is one of the most frequent genetic abnormalities in patients with this cancer, known as weighty B cell lymphoma. The MYD88 gene encodes a protein that is crucial for routine immune response to invading microorganisms.

The mutation identified in this study can cause uncontrolled cellular signaling, resulting in the survival of virulent cells. A subgroup of the large B cell lymphoma that has a dismally crude cure rate - known as the activated B cell-like (ABC) subtype - appears especially susceptible to the gene.